 |
인쇄하기
취소
|
Clevudine, 11th new drug of Korea to approve in May.
The KFDA approval of Clevudine, a drug for the treatment of B hepatitis virus, developed by Bukwang seems to be near at hand probably in coming May, which then will be the 11th new drug developed in Korea.
The KFDA took the Central Pharmaceutical Review Council's meeting on March 28 to review the NDA of Clevudine presented by Bukwang and accepted it to pass through.
Prior to the final ap...
The KFDA took the Central Pharmaceutical Review Council's meeting on March 28 to review the NDA of Clevudine presented by Bukwang and accepted it to pass through.
Prior to the final ap...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.